Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Nanoparticle formulation improves doxorubicin efficacy by enhancing host antitumor immunity.

  • Read more about Nanoparticle formulation improves doxorubicin efficacy by enhancing host antitumor immunity.
Subscribe to Journal of controlled release : official journal of the Controlled Release Society

Pediatrics Home

MAKE A GIFT

© 2026 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                   Accessibility  Privacy Policy  Terms of Use  A-Z Website List